Based on the above results, we speculate that the key targets of kaempferol in NSCLC may be PIK3R1, AKT1, EGFR, IGF1R and SRC, and the possible signaling pathway is PI3K/Akt. Here, AKT1 is linked to non-small cell lung carcinoma.